Clinical trials
Completed Lupus Nephritis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
98 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 3 |
| 2005 | 4 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 6 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 8 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 10 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 98 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aurinia Pharmaceuticals Inc. | 5 |
| Nanjing University School of Medicine | 5 |
| Novartis Pharmaceuticals | 4 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 3 |
| The University of Hong Kong | 3 |
| University Hospital, Grenoble | 3 |
| Astellas Pharma Inc | 2 |
| Boehringer Ingelheim | 2 |
| Chinese University of Hong Kong | 2 |
| Chulalongkorn University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Nephritis | 98 |
| Lupus Erythematosus, Systemic | 31 |
| Glomerulonephritis | 10 |
| Kidney Diseases | 6 |
| Nephritis | 6 |
| Glomerulonephritis, Membranoproliferative | 4 |
| Proteinuria | 4 |
| Autoimmune Diseases | 3 |
| Glomerulonephritis, IGA | 3 |
| Glomerulonephritis, Membranous | 3 |
Trials
Showing 76 to 98 of 98. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.